Laos vs Suriname: Antiretroviral therapy coverage for PMTCT
Laos
68.0%
in 2024
Suriname
66.0%
in 2024
Laos rank
54th
Suriname rank
56th
Antiretroviral therapy coverage for PMTCT over time
- Laos
- Suriname
How they compare
Laos currently reports 68.0% against 66.0% in Suriname, a difference of 2.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Suriname ahead.
Laos ranks 54th and Suriname ranks 56th of 84 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Laos | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 28.2% | 24.0% | Suriname |
| 2010s | 20.2% | 72.5% | 52.3% | Suriname |
| 2020s | 44.8% | 68.2% | 23.4% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Laos or Suriname?
- Laos, at 68.0% against 66.0% in Suriname as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Laos and Suriname?
- 2.0%, with Laos ahead.
- How many years of comparable data are there for Laos and Suriname?
- 25 years are reported by both, from 2000 to 2024.
- How do Laos and Suriname rank globally for antiretroviral therapy coverage for pmtct?
- Laos ranks 54th and Suriname ranks 56th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).